Country for PR: United Kingdom
Contributor: PR Newswire Europe
Thursday, September 14 2017 - 00:05
AsiaNet
Ascensia Diabetes Care Launches Global Innovation Competition to Find Digital Solutions to Help Tackle the Epidemic of Type 2 Diabetes
LISBON, Portugal, Sept. 13, 2017, /PRNewswire-AsiaNet/ --

Today, during the 53rd Annual Meeting of the European Association for the Study 
of Diabetes (EASD), Ascensia Diabetes Care announced the launch of the Ascensia 
Diabetes Challenge, a global innovation competition that is seeking innovative 
digital solutions to support diabetes management and improve the lives of those 
living with type 2 diabetes. The challenge aims to find new ways to help tackle 
the management of the global epidemic of type 2 diabetes by unearthing 
undiscovered solutions from diabetes innovators. Finalists, runners-up and the 
winner will all receive cash prizes to support further development of their 
ideas from a total prize fund of EUD200,000. 

Through the challenge, Ascensia aims to support companies who are developing 
the next big leap forward in digital solutions that could facilitate better 
type 2 diabetes management and help relieve the burden it places on 
individuals, healthcare systems and society. Although solutions and therapies 
in this area continue to improve year on year, many of the emerging 
technologies currently in development need further investment to ensure they 
can play a critical role in helping people with type 2 diabetes to better 
self-manage all aspects of their condition.

"At Ascensia we are excited to be launching this challenge, as we want to 
encourage innovation in our field and rethink how digital technology can help 
people with type 2 diabetes manage their day to day lives," said Michael Kloss, 
CEO Ascensia Diabetes Care. "This challenge represents the modern approach to 
finding innovative solutions for people with diabetes, alongside our own R&D. 
This challenge will not solve the diabetes epidemic on its own, but it is a 
critical step in the development of new diabetes solutions. It aims to find, 
support and nurture ideas from start-ups that have the potential to 
revolutionize diabetes management. We hope this challenge can generate novel 
ideas from undiscovered sources, and with Ascensia's support we want to be able 
to bring them to a global patient population."

The competition will seek submissions from Europe, the Americas and Asia 
Pacific with entries open from October 1, 2017 for Europe and November 6, 2017 
for Asia Pacific and the Americas. Entries can be submitted via the online 
portal at ascensiadiabeteschallenge.com.

A judging panel, made up of independent experts from diabetes and digital 
health from across the world, as well as members of the Ascensia Medical, R&D 
and Commercial teams, will assess the entries and determine finalists and the 
winner.  Dr. William Polonsky, a clinical psychologist, Dr. Masood Nazir, a 
general practitioner with a special interest in diabetes and digital health, 
and Robin Swindell, a type 2 diabetes blogger, have been confirmed as the first 
three judges, and additional judges will be announced shortly.

Dr. William Polonsky, President and Co-Founder of the Behavioral Diabetes 
Institute, San Diego, USA, explained, "Behavioral interventions are the key to 
enhancing self-management in type 2 diabetes, and digital solutions are 
desperately needed as a means to engage patients over the long-term and enable 
sustainable behavior change. Unfortunately, current digital solutions have not 
yet been able to fully address the needs of patients or effectively support 
self-management and long-term behavior change. I am thrilled to be part of the 
Ascensia Diabetes Challenge to try and find the next innovations to address the 
burden of type 2 diabetes."

Robin Swindell, a person with type 2 diabetes and active blogger from the UK 
said, "Like most patients with type 2 diabetes, I only see a healthcare 
professional for a couple of hours a year at most. For the rest of the time we 
rely on self-management. We need to find innovative digital solutions that can 
better support self-management for us. Solutions need to be able to be 
personalized and fit into their lives. They should also offer quantitative data 
that can help us to better understand and manage our condition and provide 
motivation. Digital solutions have the ability to address these needs. I am 
delighted to be involved in this challenge and hope it will unearth a new 
innovation that can make a real impact for me and other patients."

Ascensia has partnered with yet2, an open innovation services company, to 
launch this global challenge. yet2 will be managing the submission process and 
initial review of entries. They will use their experience with open innovation 
challenges to facilitate the review of entries, manage intellectual property 
screening and support the judging process.  

Michael Kloss added, "As a company that is focused on diabetes, we want to be 
driving the agenda in diabetes innovation, demonstrate our ongoing support for 
the diabetes community as a trusted partner, and show our commitment to 
continued research, innovation and development of new solutions."

For further information about Ascensia Diabetes Care, visit: 
http://www.ascensia.com.
For further information about yet2, please visit: http://www.yet2.com.

Media Contact: 
Joseph Delahunty
VP, Global Head of Communications
Ascensia Diabetes Care
E-mail: joseph.delahunty@ascensia.com
Phone: +41-79-422-9286 

Source: Ascensia Diabetes Care
Translations

Japanese